Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CORCEPT THERAPEUTICS INCCORT · Entity 2620 | Chief Business Officer | September 24, 2026 | September 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CORCEPT THERAPEUTICS INC
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,056 |
Reported balance
After 2026-09-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-24 · Gift · Disposed 17,100 · Balance 14,056 F1: Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| Common StockSEC Table I · non-derivative | IndirectCustodial Account for Child | 20,571 |
Reported balance
After 2026-09-24 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-09-24 · Gift · Acquired 5,000 · Balance 20,571 F2: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. |
| Common StockSEC Table I · non-derivative | IndirectCustodial Account for Child | 20,571 |
Reported balance
After 2026-09-24 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-24 · Gift · Acquired 5,000 · Balance 20,571 F3: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. |
| Common StockSEC Table I · non-derivative | IndirectGary Charles Robb TTE Robb Revocable Trust | 39,716 |
Reported balance
Holding disclosure · report date 2026-09-24 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 39,716 F4: These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F2: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
F3: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
F4: These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 17, 2019 Filed Feb 12, 2020 22:17 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004320 · doc5.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 3,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 17, 2019 Filed Feb 12, 2020 22:17 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004320 · doc5.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 3,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:42 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0000899243-19-028931 · doc4.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 30,000 shares Expires 2023-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:42 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 30,000 | $13.73 | $412,029.00 |
DisclosureSEC source: 0000899243-19-028931 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $13.71 to $13.79 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:42 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $1.92 | $57,600.00 |
DisclosureSEC source: 0000899243-19-028931 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:36 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000899243-19-003378 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023. Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 4 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025 Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 2,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 2,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 2,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:51 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0000899243-18-031129 · doc4.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2023-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:51 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 25,000 | $19.01 | $475,152.50 |
DisclosureSEC source: 0000899243-18-031129 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,858 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:51 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 25,000 | $1.92 | $48,000.00 |
DisclosureSEC source: 0000899243-18-031129 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2018 Filed Feb 10, 2018 01:15 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $16.52 | $0.00 |
DisclosureSEC source: 0000899243-18-003472 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-02-07 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2018, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2022. Read SEC document |
| December 26, 2017 Filed Jan 30, 2018 23:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 748 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002297 · doc4.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 1,568 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 26, 2017 Filed Jan 30, 2018 23:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 748 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002297 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 1,568 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 26, 2017 Filed Jan 30, 2018 23:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 748 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002297 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 1,568 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| September 05, 2017 Filed Dec 11, 2017 23:18 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-028495 · doc4.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 820 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| September 05, 2017 Filed Dec 11, 2017 23:18 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-028495 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 820 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| September 05, 2017 Filed Dec 11, 2017 23:18 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-028495 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 820 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| May 04, 2017 Filed May 8, 2017 21:14 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 5,600 | $9.75 | $54,588.24 |
DisclosureSEC source: 0000899243-17-012254 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,858 F1 · price: Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $9.7470 to $9.7499 per share. Detailed information on the exact number of shares purchased at each purchase price can be obtained from the issuer upon request. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 23:01 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $8.27 | $0.00 |
DisclosureSEC source: 0000899243-17-004041 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-02-10 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 10, 2017, so that the total number of shares subject to this option becomes fully vested and exercisable on February 10, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.